The Gastro-intestinal (GI) Division aims to provide and promote accessible, high quality and innovative care to patients with digestive and liver diseases. The environment is both academic and research-intensive. The division remains at the forefront of endoscopic advancements with highly specialized technical procedures.

Digestive Endoscopy

Clinically, the GI Division’s activity serves as an innovative academic model for developing and assessing endoscopic technologies and integrated management strategies. The Technology Assessment Unit in digestive endoscopy, led by the GI division, has been a major strength for the MUHC Research Institute and is recognized worldwide.

Inflammatory Bowel Disease

In Quebec and Canada, the MUHC’s GI division is unique for its Inflammatory Bowel Disease (IBD) Program. Dedicated clinicians are consolidating the MUHC’s contribution of data and research in this field, and strengthen its teaching programs.

Hepatology and Liver Transplantation

The division’s Clinical Hepatology and Liver Transplantation activities are highly specialized and represent a distinct collaboration between the MUHC and the University of Montreal Hospital Centre

Esophageal disease

The Division’s Advanced endoscopic procedures are used in treating esophageal disease and its multi-disciplinary approach is unique to the MUHC. The growing need for GI Transition clinics is being met by the Division’s initiatives. The existing collaboration with other specialized divisions, such as Colorectal and Thoracic Surgery, is evolving into a broader cross-disciplinary Digestive Disease program.